Pfizer Inc. (NYSE:PFE) is included among the 13 Best January Dividend Stocks to Invest in. Pfizer Inc. (NYSE:PFE) is among ...
According to healthcare research firm 3 Axis Advisors, drugmakers are planning to raise U.S. prices on medications including ...
CNN reports the increase is up from 250 last year, but the median is around 4% which is in line with 2025. Drugmakers point ...
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Semaglutide, the popular drug sold by Novo Nordisk as ...
US pharmaceutical firms plan to increase list prices on at least 350 branded medicines in 2026, including key Covid vaccines ...
The price hikes come even as the Trump administration pressures pharmaceutical companies to lower costs for patients.
The breast cancer medication Ibrance has been the shooting star in Pfizer’s universe, and it’s expected to burn brightly enough to raise the entire company’s fortunes. That’s despite Ibrance’s ...
The Pharmacy Board has warned of falsified IBRANCE breast cancer drugs after a WHO alert, urging vigilance to protect patients.
First Cyclin-Dependent Kinase 4/6 (CDK 4/6) Inhibitor Approved by the FDA IBRANCE Now Available for Use in Combination with Letrozole as First-Line Treatment of Postmenopausal Women with Estrogen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback